Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
|
July 25, 2022
Prenatal phenotyping: A community effort to enhance the Human Phenotype Ontology
Ferdinand Dhombres, Patricia Morgan, Bimal P Chaudhari, et al.
The New England Journal of Medicine
|
August 3, 2022
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria
Richard L Wu, Azza H Idris, Nina M Berkowitz, et al.
The Lancet. Infectious Diseases
|
August 6, 2023
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial
Betty Mwesigwa, Katherine V Houser, Amelia R Hofstetter, et al.
Lancet (London, England)
|
January 28, 2023
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial
Melinda J Hamer, Katherine V Houser, Amelia R Hofstetter, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
|
July 25, 2022
Prenatal phenotyping: A community effort to enhance the Human Phenotype Ontology
Ferdinand Dhombres, Patricia Morgan, Bimal P Chaudhari, et al.
The New England Journal of Medicine
|
August 3, 2022
Low-Dose Subcutaneous or Intravenous Monoclonal Antibody to Prevent Malaria
Richard L Wu, Azza H Idris, Nina M Berkowitz, et al.
The Lancet. Infectious Diseases
|
August 6, 2023
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial
Betty Mwesigwa, Katherine V Houser, Amelia R Hofstetter, et al.
Lancet (London, England)
|
January 28, 2023
Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial
Melinda J Hamer, Katherine V Houser, Amelia R Hofstetter, et al.
Page
of 3